| The evolution of an integrated ultrasound curriculum (iUSC) for medical students: 9-year experience RA Hoppmann, VV Rao, F Bell, MB Poston, DB Howe, S Riffle, S Harris, ... Critical ultrasound journal 7, 1-15, 2015 | 198 | 2015 |
| An overview of insulin pumps and glucose sensors for the generalist BH McAdams, AA Rizvi Journal of clinical medicine 5 (1), 5, 2016 | 148 | 2016 |
| Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: a 6 months prospective study PP Toth, AM Patti, D Nikolic, RV Giglio, G Castellino, T Biancucci, ... Frontiers in pharmacology 6, 299, 2016 | 147 | 2016 |
| Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts AA Rizvi The American journal of the medical sciences 338 (4), 310-318, 2009 | 146 | 2009 |
| Perioperative management of diabetes and hyperglycemia in patients undergoing orthopaedic surgery AA Rizvi, SA Chillag, KJ Chillag JAAOS-Journal of the American Academy of Orthopaedic Surgeons 18 (7), 426-435, 2010 | 130 | 2010 |
| Diabetes and the COVID-19 pandemic: how insights from recent experience might guide future management AP Stoian, Y Banerjee, AA Rizvi, M Rizzo Metabolic syndrome and related disorders 18 (4), 173-175, 2020 | 128 | 2020 |
| Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study M Rizzo, AA Rizvi, AM Patti, D Nikolic, RV Giglio, G Castellino, G Li Volti, ... Cardiovascular Diabetology 15, 1-8, 2016 | 128 | 2016 |
| GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms M Rizzo, D Nikolic, AM Patti, C Mannina, G Montalto, BS McAdams, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (9 …, 2018 | 126 | 2018 |
| Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study M Rizzo, M Chandalia, AM Patti, V Di Bartolo, AA Rizvi, G Montalto, ... Cardiovascular diabetology 13, 1-5, 2014 | 126 | 2014 |
| Severe primary hypothyroidism manifesting with torsades de pointes JB Schenck, AA Rizvi, T Lin The American journal of the medical sciences 331 (3), 154-156, 2006 | 126 | 2006 |
| Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study M Rizzo, N Abate, M Chandalia, AA Rizvi, RV Giglio, D Nikolic, ... The journal of clinical endocrinology & metabolism 100 (2), 603-606, 2015 | 115 | 2015 |
| Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors M Rizzo, AA Rizvi, GA Spinas, GB Rini, K Berneis Expert opinion on investigational drugs 18 (10), 1495-1503, 2009 | 114 | 2009 |
| Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients: evidence for a central role of adipose tissue F Abbasi, V Kamath, AA Rizvi, M Carantoni, YDI Chen, GM Reaven Diabetes care 20 (12), 1863-1869, 1997 | 95 | 1997 |
| Incidence of diabetes mellitus in a population‐based cohort of HIV‐infected and non‐HIV‐infected persons: the impact of clinical and therapeutic factors over time A Tripathi, AD Liese, JM Jerrell, J Zhang, AA Rizvi, H Albrecht, WA Duffus Diabetic medicine 31 (10), 1185-1193, 2014 | 89 | 2014 |
| Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults M Kurella Tamura, NM Pajewski, RN Bryan, DE Weiner, M Diamond, ... Neurology 86 (13), 1208-1216, 2016 | 66 | 2016 |
| Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach AA Rizvi Southern Medical Journal 97 (11), 1079-1088, 2004 | 63 | 2004 |
| Nutritional challenges in the elderly with diabetes AA Rizvi International journal of diabetes mellitus 1 (1), 26-31, 2009 | 62 | 2009 |
| Levofloxacin-induced hypoglycemia in a nondiabetic patient S Wang, AA Rizvi The American journal of the medical sciences 331 (6), 334-335, 2006 | 61 | 2006 |
| Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia? M Rizzo, M Barylski, AA Rizvi, G Montalto, D P Mikhailidis, M Banach Current pharmaceutical design 19 (21), 3858-3868, 2013 | 59 | 2013 |
| Liraglutide reduces carotid intima-media thickness by reducing small dense low-density lipoproteins in a real-world setting of patients with type 2 diabetes: A novel anti … D Nikolic, RV Giglio, AA Rizvi, AM Patti, G Montalto, F Maranta, ... Diabetes Therapy 12, 261-274, 2021 | 54 | 2021 |
